CN Stock MarketDetailed Quotes

688091 Shanghai Yizhong Pharmaceutical

Watchlist
  • 42.97
  • -3.02-6.57%
Market Closed Nov 29 15:00 CST
8.84BMarket Cap134.70P/E (TTM)

Shanghai Yizhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-39.25%169.61M
-39.17%121.92M
-25.65%68.7M
52.68%360.25M
67.87%279.2M
178.88%200.43M
169.06%92.4M
5,686.75%235.96M
166.32M
71.87M
Operating revenue
-39.25%169.61M
-39.17%121.92M
-25.65%68.7M
52.68%360.25M
67.87%279.2M
178.88%200.43M
169.06%92.4M
5,686.75%235.96M
--166.32M
--71.87M
Total operating cost
10.44%136.61M
10.57%84.81M
38.38%37M
58.58%168.3M
72.00%123.69M
326.22%76.7M
180.22%26.74M
323.59%106.13M
224.36%71.91M
36.96%18M
Operating cost
-51.39%9.19M
-52.46%6.6M
-47.45%3.73M
38.99%23.59M
60.37%18.91M
150.76%13.88M
206.46%7.1M
5,636.79%16.97M
--11.79M
--5.53M
Operating tax surcharges
-34.57%814.72K
-35.04%579.26K
-22.76%324.38K
78.03%1.61M
129.07%1.25M
333.09%891.67K
6,969.03%419.94K
3,458.89%904.66K
2,511.81%543.61K
1,142.76%205.89K
Operating expense
6.36%83.79M
10.21%53.49M
73.01%25.58M
19.77%106.63M
32.45%78.78M
325.22%48.53M
209.77%14.79M
3,740.98%89.03M
11,941.78%59.47M
--11.41M
Administration expense
10.09%31.13M
6.56%18.95M
-2.02%8.38M
325.92%40.94M
327.64%28.28M
316.39%17.79M
284.55%8.55M
-35.81%9.61M
-44.89%6.61M
-28.92%4.27M
Financial expense
32.45%-13.66M
24.16%-10.14M
1.64%-6.61M
-46.99%-26.92M
-79.64%-20.23M
-124.06%-13.37M
-444.49%-6.72M
-215.85%-18.32M
-243.51%-11.26M
-203.36%-5.97M
-Interest expense (Financial expense)
225.62%699.68K
396.41%592.94K
299.37%266.54K
3,248.37%269.96K
-56.28%214.88K
-14.40%119.44K
171.09%66.74K
-101.46%-8.57K
18.02%491.43K
-39.28%139.54K
-Interest Income (Financial expense)
29.46%-14.45M
20.07%-10.82M
-1.32%-6.88M
-48.72%-27.25M
-74.24%-20.49M
-121.51%-13.54M
-493.67%-6.79M
-186.11%-18.32M
-217.23%-11.76M
-177.17%-6.11M
Research and development
51.70%25.34M
70.62%15.33M
114.99%5.6M
183.26%22.45M
251.84%16.71M
254.02%8.99M
78.71%2.6M
-40.14%7.93M
-63.29%4.75M
-72.04%2.54M
Credit Impairment Loss
117.60%881.48K
105.85%239.1K
131.56%558.91K
-167.23%-5.43M
-213.97%-5.01M
-174.77%-4.09M
-148.26%-1.77M
-840.77%-2.03M
---1.6M
---1.49M
Asset Impairment Loss
---4.24K
----
----
---36.75K
----
----
----
----
----
----
Other net revenue
Fair value change income
-99.08%8.05K
-58.36%708.26K
-61.72%333.83K
-53.35%418.49K
-23.83%880.27K
104.35%1.7M
327.48%872.05K
-72.39%897.09K
1,425.36%1.16M
1,983.89%832.34K
Invest income
48.82%7.37M
51.55%3.52M
34.82%1.49M
-40.81%7.1M
-48.06%4.95M
-67.29%2.32M
-79.29%1.1M
447.22%12M
980.05%9.54M
1,535.96%7.1M
Other revenue
63.24%1.15M
97.02%967.96K
29.24%361.65K
-86.74%1.45M
-39.13%704.79K
13.89%491.31K
27.25%279.83K
68.43%10.9M
77.87%1.16M
-1.70%431.38K
Operating profit
-73.00%42.41M
-65.73%42.55M
-47.92%34.45M
28.94%195.45M
50.04%157.04M
104.38%124.15M
121.73%66.15M
1,733.23%151.59M
605.06%104.67M
596.87%60.75M
Add:Non operating Income
-54.97%1.08K
-55.00%1.08K
----
300.00%2.4K
300.00%2.4K
--2.4K
--2.4K
--600
-99.90%600
----
Less:Non operating expense
-25.30%4.31M
16.47%3.61M
-46.53%976.5K
322.23%8.56M
306.66%5.77M
329.06%3.1M
--1.83M
--2.03M
--1.42M
--722.68K
Total profit
-74.81%38.1M
-67.84%38.94M
-47.97%33.47M
24.97%186.9M
46.52%151.28M
101.67%121.06M
115.62%64.32M
1,711.40%149.56M
613.07%103.25M
590.96%60.03M
Less:Income tax cost
-83.39%3.43M
-73.87%4.43M
-53.85%4.29M
277.93%25.35M
2,351.12%20.65M
1,877.37%16.95M
1,118.76%9.3M
226.91%6.71M
---917.41K
---953.48K
Net profit
-73.46%34.67M
-66.85%34.51M
-46.97%29.18M
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
Net profit from continuing operation
-73.46%34.67M
-66.85%34.51M
-46.97%29.18M
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
Net profit of parent company owners
-73.46%34.67M
-66.85%34.51M
-46.97%29.18M
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
Earning per share
Basic earning per share
-79.52%0.17
-74.24%0.17
-52.63%0.18
3.03%1.02
-15.31%0.83
13.79%0.66
31.03%0.38
2,080.00%0.99
508.33%0.98
486.67%0.58
Diluted earning per share
-79.52%0.17
-74.24%0.17
-52.63%0.18
3.03%1.02
-15.31%0.83
13.79%0.66
31.03%0.38
2,080.00%0.99
508.33%0.98
486.67%0.58
Other composite income
Total composite income
-73.46%34.67M
-66.85%34.51M
-46.97%29.18M
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
Total composite income of parent company owners
-73.46%34.67M
-66.85%34.51M
-46.97%29.18M
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -39.25%169.61M-39.17%121.92M-25.65%68.7M52.68%360.25M67.87%279.2M178.88%200.43M169.06%92.4M5,686.75%235.96M166.32M71.87M
Operating revenue -39.25%169.61M-39.17%121.92M-25.65%68.7M52.68%360.25M67.87%279.2M178.88%200.43M169.06%92.4M5,686.75%235.96M--166.32M--71.87M
Total operating cost 10.44%136.61M10.57%84.81M38.38%37M58.58%168.3M72.00%123.69M326.22%76.7M180.22%26.74M323.59%106.13M224.36%71.91M36.96%18M
Operating cost -51.39%9.19M-52.46%6.6M-47.45%3.73M38.99%23.59M60.37%18.91M150.76%13.88M206.46%7.1M5,636.79%16.97M--11.79M--5.53M
Operating tax surcharges -34.57%814.72K-35.04%579.26K-22.76%324.38K78.03%1.61M129.07%1.25M333.09%891.67K6,969.03%419.94K3,458.89%904.66K2,511.81%543.61K1,142.76%205.89K
Operating expense 6.36%83.79M10.21%53.49M73.01%25.58M19.77%106.63M32.45%78.78M325.22%48.53M209.77%14.79M3,740.98%89.03M11,941.78%59.47M--11.41M
Administration expense 10.09%31.13M6.56%18.95M-2.02%8.38M325.92%40.94M327.64%28.28M316.39%17.79M284.55%8.55M-35.81%9.61M-44.89%6.61M-28.92%4.27M
Financial expense 32.45%-13.66M24.16%-10.14M1.64%-6.61M-46.99%-26.92M-79.64%-20.23M-124.06%-13.37M-444.49%-6.72M-215.85%-18.32M-243.51%-11.26M-203.36%-5.97M
-Interest expense (Financial expense) 225.62%699.68K396.41%592.94K299.37%266.54K3,248.37%269.96K-56.28%214.88K-14.40%119.44K171.09%66.74K-101.46%-8.57K18.02%491.43K-39.28%139.54K
-Interest Income (Financial expense) 29.46%-14.45M20.07%-10.82M-1.32%-6.88M-48.72%-27.25M-74.24%-20.49M-121.51%-13.54M-493.67%-6.79M-186.11%-18.32M-217.23%-11.76M-177.17%-6.11M
Research and development 51.70%25.34M70.62%15.33M114.99%5.6M183.26%22.45M251.84%16.71M254.02%8.99M78.71%2.6M-40.14%7.93M-63.29%4.75M-72.04%2.54M
Credit Impairment Loss 117.60%881.48K105.85%239.1K131.56%558.91K-167.23%-5.43M-213.97%-5.01M-174.77%-4.09M-148.26%-1.77M-840.77%-2.03M---1.6M---1.49M
Asset Impairment Loss ---4.24K-----------36.75K------------------------
Other net revenue
Fair value change income -99.08%8.05K-58.36%708.26K-61.72%333.83K-53.35%418.49K-23.83%880.27K104.35%1.7M327.48%872.05K-72.39%897.09K1,425.36%1.16M1,983.89%832.34K
Invest income 48.82%7.37M51.55%3.52M34.82%1.49M-40.81%7.1M-48.06%4.95M-67.29%2.32M-79.29%1.1M447.22%12M980.05%9.54M1,535.96%7.1M
Other revenue 63.24%1.15M97.02%967.96K29.24%361.65K-86.74%1.45M-39.13%704.79K13.89%491.31K27.25%279.83K68.43%10.9M77.87%1.16M-1.70%431.38K
Operating profit -73.00%42.41M-65.73%42.55M-47.92%34.45M28.94%195.45M50.04%157.04M104.38%124.15M121.73%66.15M1,733.23%151.59M605.06%104.67M596.87%60.75M
Add:Non operating Income -54.97%1.08K-55.00%1.08K----300.00%2.4K300.00%2.4K--2.4K--2.4K--600-99.90%600----
Less:Non operating expense -25.30%4.31M16.47%3.61M-46.53%976.5K322.23%8.56M306.66%5.77M329.06%3.1M--1.83M--2.03M--1.42M--722.68K
Total profit -74.81%38.1M-67.84%38.94M-47.97%33.47M24.97%186.9M46.52%151.28M101.67%121.06M115.62%64.32M1,711.40%149.56M613.07%103.25M590.96%60.03M
Less:Income tax cost -83.39%3.43M-73.87%4.43M-53.85%4.29M277.93%25.35M2,351.12%20.65M1,877.37%16.95M1,118.76%9.3M226.91%6.71M---917.41K---953.48K
Net profit -73.46%34.67M-66.85%34.51M-46.97%29.18M13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M
Net profit from continuing operation -73.46%34.67M-66.85%34.51M-46.97%29.18M13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M
Net profit of parent company owners -73.46%34.67M-66.85%34.51M-46.97%29.18M13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M
Earning per share
Basic earning per share -79.52%0.17-74.24%0.17-52.63%0.183.03%1.02-15.31%0.8313.79%0.6631.03%0.382,080.00%0.99508.33%0.98486.67%0.58
Diluted earning per share -79.52%0.17-74.24%0.17-52.63%0.183.03%1.02-15.31%0.8313.79%0.6631.03%0.382,080.00%0.99508.33%0.98486.67%0.58
Other composite income
Total composite income -73.46%34.67M-66.85%34.51M-46.97%29.18M13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M
Total composite income of parent company owners -73.46%34.67M-66.85%34.51M-46.97%29.18M13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data